Home›Research›Compare›Angiotensin (1-7) vs NAD+
Peptide ComparisonAngiotensin (1-7) vs NAD+
Both are Longevity & Cellular peptides.
Angiotensin (1-7)
Ang-(1-7)
Half-life: ~9–10 sec (rat)
No providers listed yet
NAD+
NAD
Half-life: ~1–2 hours (IV); variable (oral)
509 providers listed
Angiotensin (1-7) carries stronger published evidence (RCT, 9 key studies) than NAD+ (RCT, 4); both are research compounds.
Angiotensin (1-7)
Half-life
~9–10 sec (rat)
NAD+
Half-life
~1–2 hours (IV); variable (oral)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Angiotensin (1-7) |
| Further along in FDA review | Angiotensin (1-7) |
| Less frequent dosing (longer half-life) | Angiotensin (1-7) |
| Oral administration option | NAD+ |
| More provider options (0 vs 509) | NAD+ |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Angiotensin (1-7)
NAD+
Angiotensin (1-7)
Association between renin angiotensin system and cognitive outcomes over 15 years: The Look AHEAD study.
Angiotensin-(1-7) improves oxygenation in mechanically ventilated COVID-19 patients: a randomized phase 1-2 s…
Perioperative Angiotensin-(1-7) for Postoperative Cognitive Vulnerability Following Coronary Artery Bypass Su…
The Effect of Angiotensin (1-7) on Serum Metabolomics in Obese Type 2 Diabetic Mice.
+5 more
NAD+
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and…
Mitochondrial quality control in human ageing and longevity.
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
About Angiotensin (1-7)
Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.
About NAD+
NAD+ is a coenzyme central to cellular energy metabolism, serving as an electron carrier in glycolysis, the citric acid cycle, and oxidative phosphorylation. It is also a required substrate for sirtuins (SIRT1–7) and PARP enzymes, which regulate DNA repair, gene expression, and mitochondrial biogenesis. NAD+ levels decline measurably with age; IV or subcutaneous delivery aims to restore intracellular pools more directly than oral precursors such as NMN or NR.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Angiotensin (1-7)
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
NAD+
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Angiotensin (1-7)
Not enough vendor pricing yet.
NAD+
Where to source these peptides
Angiotensin (1-7)
Browse directory →
Providers offeringNAD+
509 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated October 27, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Angiotensin (1-7) vs NAD+ — Per-mg Price Comparison. Retrieved October 27, 2026, from https://peptidebase.io/peptides/compare/angiotensin-1-7/nad-plus